Fortaleza Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Fortaleza Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$206K	Sell	1,595 -721	-31%	-$80.5K	1.67%	5
2018 Q1	$239K	Hold	2,316	–	–	1.45%	18
2017 Q4	$198K	Hold	2,316	–	–	1.24%	32
2017 Q3	$197K	Hold	2,316	–	–	0.36%	86
2017 Q2	$175K	Hold	2,316	–	–	0.33%	87
2017 Q1	$153K	Hold	2,316	–	–	0.31%	104
2016 Q4	$147K	Hold	2,316	–	–	0.31%	95
2016 Q3	$147K	Hold	2,316	–	–	0.21%	92
2016 Q2	$172K	Sell	2,316 -1,187	-34%	-$88.1K	0.14%	73
2016 Q1	$234K	Hold	3,503	–	–	0.15%	77
2015 Q4	$237K	Sell	3,503 -80	-2%	-$4.94K	0.14%	83
2015 Q3	$191K	Buy	3,583 +1,267	+55%	+$76.9K	0.13%	109
2015 Q2	$146K	Buy	+2,316	New	+$126K	0.09%	141

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fortaleza Asset Management's LGND Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Ligand Pharmaceuticals (LGND) stake by 31% in Q2 2018, selling an estimated $80.5K and leaving 1,595 shares worth $206K. The position accounts for 1.67% of the portfolio, ranked #5.

Fortaleza Asset Management first reported a position in LGND in Q2 2015 and has held it in 13 quarters since. The position peaked at $239K in Q1 2018. 346 funds tracked by Wall St. Rank hold LGND as of Q2 2018.

Fortaleza Asset Management held 1,595 shares of Ligand Pharmaceuticals worth $206K as of Q2 2018.
Fortaleza Asset Management sold 721 Ligand Pharmaceuticals shares in Q2 2018, an estimated $80.5K.
Ligand Pharmaceuticals made up 1.67% of Fortaleza Asset Management's portfolio in Q2 2018, its #5 holding.
Fortaleza Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
Fortaleza Asset Management's Ligand Pharmaceuticals position peaked at $239K in Q1 2018.
346 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.